Search results
Results from the WOW.Com Content Network
Parents across the US are beginning to face the struggles of a second winter without enough supplies of amoxicillin, the most prescribed antibiotic in the country.
Oral fosfomycin is not recommended for children under 12 years old. [15] Additional uses have been proposed. [16] The global problem of advancing antimicrobial resistance has led to a renewed interest in its use more recently. [17] Fosfomycin can be used as an efficacious treatment for both UTIs and complicated UTIs including acute pyelonephritis.
Antibiotic resistance—when bacteria change so antibiotics no longer work in people who need them to treat infections—is now a major threat to public health." [16] Each year, nearly 5 million deaths are associated with AMR globally. [6] In 2019, global deaths attributable to AMR numbered 1.27 million in 2019.
In France, an "Antibiotics are not automatic" government campaign started in 2002 and led to a marked reduction of unnecessary antibiotic prescriptions, especially in children. [ 114 ] The emergence of antibiotic resistance has prompted restrictions on their use in the UK in 1970 (Swann report 1969), and the European Union has banned the use of ...
Despite acute respiratory-tract infections being mainly caused by viruses, as many as 75% of cases are treated with antibiotics. [12] When children with ear tubes get ear infections, they should have antibiotic eardrops put into their ears to go to the infection rather than having oral antibiotics, which are more likely to have unwanted side ...
Pfizer cross-appealed denial of its motion to dismiss pursuant to Rule 12(b)(6) of the Federal Rules of Civil Procedure. The Court of Appeals reviewed the forum non conveniens dismissal under the "clear abuse of discretion" standard. [citation needed] The Court of Appeals, however, revisited the Court's analysis of the adequate alternative ...
β-Lactam antibiotics are indicated for the prevention and treatment of bacterial infections caused by susceptible organisms. At first, β-lactam antibiotics were mainly active only against gram-positive bacteria, yet the recent development of broad-spectrum β-lactam antibiotics active against various gram-negative organisms has increased their usefulness.
Narrow-spectrum antibiotics have low propensity to induce bacterial resistance and are less likely to disrupt the microbiome (normal microflora). [3] On the other hand, indiscriminate use of broad-spectrum antibiotics may not only induce the development of bacterial resistance and promote the emergency of multidrug-resistant organisms, but also cause off-target effects due to dysbiosis.